The human LT system. VIII. A target cell-dependent enzymatic activation step required for the expression of the cytotoxic activity of human lymphotoxin.
D015119:Aminocaproic Acid / Q000494:pharmacology; D000818:Animals; D003602:Cytotoxicity, Immunologic; D004950:Esterases / Q000378:metabolism; D006801:Humans; D007531:Isoflurophate / Q000494:pharmacology; D008233:Lymphotoxin-alpha / Q000494:pharmacology*; D051379:Mice; D011480:Protease Inhibitors / Q000494:pharmacology*; D014106:Tosylarginine Methyl Ester / Q000494:pharmacology; D014107:Tosyllysine Chloromethyl Ketone / Q000494:pharmacology; D014361:Trypsin Inhibitors / Q000494:pharmacology
D008233:Lymphotoxin-alpha; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D007531:Isoflurophate; D014107:Tosyllysine Chloromethyl Ketone; D014106:Tosylarginine Methyl Ester; D004950:Esterases; D015119:Aminocaproic Acid